1. Home
  2. BNR vs IOTR Comparison

BNR vs IOTR Comparison

Compare BNR & IOTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • IOTR
  • Stock Information
  • Founded
  • BNR 2014
  • IOTR 2019
  • Country
  • BNR China
  • IOTR Singapore
  • Employees
  • BNR N/A
  • IOTR N/A
  • Industry
  • BNR Medical Specialities
  • IOTR
  • Sector
  • BNR Health Care
  • IOTR
  • Exchange
  • BNR Nasdaq
  • IOTR NYSE
  • Market Cap
  • BNR 38.3M
  • IOTR 11.5M
  • IPO Year
  • BNR 2020
  • IOTR 2025
  • Fundamental
  • Price
  • BNR $6.47
  • IOTR $0.47
  • Analyst Decision
  • BNR
  • IOTR
  • Analyst Count
  • BNR 0
  • IOTR 0
  • Target Price
  • BNR N/A
  • IOTR N/A
  • AVG Volume (30 Days)
  • BNR 53.8K
  • IOTR 693.0K
  • Earning Date
  • BNR 08-21-2025
  • IOTR 01-01-0001
  • Dividend Yield
  • BNR N/A
  • IOTR N/A
  • EPS Growth
  • BNR N/A
  • IOTR N/A
  • EPS
  • BNR N/A
  • IOTR N/A
  • Revenue
  • BNR $72,112,038.00
  • IOTR $10,478,550.00
  • Revenue This Year
  • BNR $136.32
  • IOTR N/A
  • Revenue Next Year
  • BNR N/A
  • IOTR N/A
  • P/E Ratio
  • BNR N/A
  • IOTR N/A
  • Revenue Growth
  • BNR 0.53
  • IOTR 22.27
  • 52 Week Low
  • BNR $2.18
  • IOTR $0.31
  • 52 Week High
  • BNR $9.48
  • IOTR $5.98
  • Technical
  • Relative Strength Index (RSI)
  • BNR 60.79
  • IOTR N/A
  • Support Level
  • BNR $5.81
  • IOTR N/A
  • Resistance Level
  • BNR $9.48
  • IOTR N/A
  • Average True Range (ATR)
  • BNR 0.90
  • IOTR 0.00
  • MACD
  • BNR 0.12
  • IOTR 0.00
  • Stochastic Oscillator
  • BNR 45.86
  • IOTR 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About IOTR IOTHREE LIMITED

iOThree Ltd is a provider of maritime digital technologies, including satellite connectivity and digitalization solutions in Singapore, focused on facilitating the maritime industry towards digital transformation. It offers shipboard infrastructure to customers by designing and installing the necessary satellite connectivity solution, IT equipment, shipboard equipment (such as equipment relating to navigation systems, automatic identification system, etc.), and JARVISS, a digitalization platform on the vessels of customers. The group's operating segments are: Satellite connectivity solution, which generates key revenue, and Digitalization and other solution. Geographically, it generates maximum revenue from Singapore, and rest from Israel, Malaysia, Vietnam, Thailand, and other regions.

Share on Social Networks: